$RDHL "has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID) to provide its investigational drug, RHB-107 (upamostat, WX-671)1, for testing in non-clinical studies for activity against SARS-CoV-2"

#daytrading #stocks